Hi everyone,

I would like to identify ovarian cancer stem cells using ALDH+CD133+ signature. In the literature groups have used antibodies against either CD133/1 or CD133/2.  Is there any difference or reason to choose one epitope over another when trying to identify cancer stem cells? Many thanks!

Similar questions and discussions